From the publishers of JADPRO

Bone Protection Resource Center

Advertisement

Differences between zoledronic acid and denosumab for breast cancer treatment

Last Updated: Friday, July 17, 2026

In this review article, researchers discuss the use of zoledronic acid and denosumab in the treatment of breast cancer, including prevention of cancer treatment–induced bone loss, prevention and treatment of bone metastases, and improvement of survival. 

Journal of Bone and Mineral Metabolism
Advertisement
Advertisement